Shreegen Pharma Limited, a active public limited company, was established on 18 October 2012 in Ameerpet, Telangana, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24233TG2012PLC083695. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹25.00 Cr and a paid-up capital of ₹25.00 Cr.
Formerly known as Shree Gen Pharma Limited. It upholds a compliant status. Employing 26 professional, Its leadership includes Rama Mangeswar Reddy Bobbiti (Managing Director), Kanaka Nallamilli Sundara Reddy (Director), Chandra Balireddy Kotthapalli (Additional Director). Past directors included Rama Mangeswar Reddy Bobbiti, Naveen Kumar Kotla, Bobbiti Venkata Rami Reddy. It holds ₹11.69 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at Hno. 7-1-638 To 643 Flat 305, Bhanu Enclave, Beside Esi Hospital, Sundernagar,Erragadda, Ameerpet, Telangana, 500038.
U24233TG2012PLC083695
083695
18 October 2012
₹25.00 Cr
₹25.00 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Shreegen Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rama Mangeswar Reddy Bobbiti | Managing Director | 18 Oct 2012 | Current |
| Kanaka Nallamilli Sundara Reddy | Director | 30 Sep 2016 | Current |
| Chandra Balireddy Kotthapalli | Additional Director | 14 May 2025 | Current |
| Srinivasa Reddy Daka | Director | 18 Oct 2012 | Current |
| Rajeev Dinesh Srivastava | Additional Director | 14 May 2025 | Current |
| Sishtla Ramakrishnan | Director | 01 Aug 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Oct 2016 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
| Pramod Abcsdd | Director | 25 Mar 2014 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
| Pramod Abcsdd | Director | 16 Feb 2019 | Past |
| Pramod Abcsdd | Cfo | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Shreegen Pharma Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 52.92% decrease. The company also saw a substantial fall in profitability, with a 6104.85% decrease in profit. The company's net worth observed a substantial decline by a decrease of 62.59%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Shreegen Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹116,900,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Apr 2015 | State Bank Of India | ₹11.69 Cr | Open |
Explore comprehensive loan charge details -
Shreegen Pharma has a workforce of 26 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Shreegen Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shreegen Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Sishtla Ramakrishnan was appointed as a Director was appointed as a Director on 01 Aug 2025 & has been associated with this company since 4 months 2 days . was documented.
Progress on Chandra Balireddy Kotthapalli was appointed as a Additional Director was appointed as a Additional Director on 14 May 2025 & has been associated with this company since 6 months 20 days . was documented.
The activity Rajeev Dinesh Srivastava was appointed as a Additional Director was appointed as a Additional Director on 14 May 2025 & has been associated with this company since 6 months 20 days . was completed.
Progress on Shreegen Pharma Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was documented.
Progress on Shreegen Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad. was documented.
Progress on A charge with State Bank Of India of Rs. 11.69 Cr registered on 13 Apr 2015 with Charge ID 10569557 was modified on 29 Sep 2021. was documented.
The CIN of Shreegen Pharma Limited is U24233TG2012PLC083695.
Shreegen Pharma Limited is headquartered at Hno. 7-1-638 To 643 Flat 305, Bhanu Enclave, Beside Esi Hospital, Sundernagar,Erragadda, Ameerpet, Telangana, 500038.
Shreegen Pharma Limited was incorporated on 18 October 2012.
The current directors of Shreegen Pharma Limited are
The primary industry of Shreegen Pharma Limited is Manufacturing.
Shreegen Pharma Limited is unlisted.
The authorized capital of Shreegen Pharma Limited is ₹25.00 Cr, and the paid-up capital is ₹25.00 Cr.
The compliance status of Shreegen Pharma Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX